Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Additional Reports Of Exempt Distribution.

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Additional Reports Of Exempt Distribution.

KOO-KOO2

Jun 05, 2024 07:03AM

Re: Additional Reports Of Exempt Distribution.

fuzzyjr

Jun 05, 2024 04:27PM

Re: Additional Reports Of Exempt Distribution.

KOO-KOO2

Jun 05, 2024 08:46PM

fuzzyjr

Rank: Vice President [?]

Points: 5057 [?]

Votes: 36 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Additional Reports Of Exempt Distribution.

in response to

Re: Additional Reports Of Exempt Distribution.

KOO-KOO2

posted on Jun 05, 2024 09:18PM

"However, we can't be in a blackout period because Zenith just issued warrants to (most likely) insiders and friends vis a vis, exempt distribution and Resverlogix issued securities to insiders as reported on SEDI, on June 4, 2024."

Guess it's safe to say donny & his motley crew have FA going on "behind the scenes" same old BS

Re: Additional Reports Of Exempt Distribution.

tada

Jun 05, 2024 10:55PM

Re: Additional Reports Of Exempt Distribution.

fuzzyjr

Jun 05, 2024 11:17PM

Re: Additional Reports Of Exempt Distribution.

fuzzyjr

Jun 05, 2024 11:28PM

Re: Additional Reports Of Exempt Distribution.

KOO-KOO2